Full Alliance Group Obtains FDA MOCRA Registration for HOCl Platform
Market Timing Meets Regulatory Excellence
The successful completion of third-party Human Repeat Insult Patch Testing (RIPT) for Aquaox's HOCl Hydrogel and FDA MOCRA registration for Aquaox's HOCl arrives as consumer demand for science-backed, non-toxic personal care solutions reaches unprecedented levels. With 73% of consumers actively seeking products free from harsh chemicals and synthetic preservatives, Aquaox's breakthrough validates the market shift toward gentle, effective alternatives.
'We're not just responding to market trends—we're helping define them,' said Michel Van Schaik, President of Aquaox Pure Solutions. 'While competitors struggle with regulatory compliance and formulation challenges, we've built a platform that delivers both safety and scalability in a market hungry for clean solutions.'
Disrupting Traditional Categories Through Innovation
Aquaox's FDA MOCRA registration positions the company as a rare turnkey partner capable of supporting private-label brands and healthcare entrepreneurs entering regulated retail channels including Amazon, TikTok Shop, grocery, chain pharmacies and other big box retailers. This regulatory advantage creates significant barriers for competitors while opening lucrative distribution partnerships in a market where compliance increasingly determines market access.
The company's proprietary nanobubble HOCl technology addresses critical industry pain points including product stability, shelf-life limitations, and manufacturing consistency—challenges that have historically prevented widespread HOCl adoption despite growing consumer awareness of its benefits.
Capturing Multiple High-Growth Verticals
Aquaox's platform strategy targets three converging market opportunities:
Clean Beauty & Personal Care: The $13.2 billion clean beauty market continues its 9.7% CAGR as consumers abandon traditional antiseptics and alcohol-based products for gentler alternatives. Aquaox's RIPT-certified formulations directly address this shift.
E-commerce & Digital-First Brands: With 67% of beauty purchases now influenced by social media, Aquaox's MOCRA compliance enables private-label partners to capitalize on the direct-to-consumer boom across major digital marketplaces.
Healthcare & Clinical Applications: The $4.2 billion infection prevention market increasingly demands non-toxic, effective solutions. Aquaox's GMP-compliant manufacturing addresses growing hospital and clinical demand for safer antiseptic alternatives.
JusSpray™: Consumer Market Validation
The company's flagship consumer product, JusSpray™ (www.jusspray.com), serves as both revenue generator and market proof-of-concept. This alcohol-free, fragrance-free HOCl spray demonstrates consumer acceptance of advanced hypochlorous formulations while establishing Aquaox's direct-to-consumer capabilities.
'JusSpray™ isn't just a product—it's validation that consumers are ready for science-backed alternatives to traditional sanitizers and skin care products,' added Van Schaik. 'Every bottle sold proves our manufacturing quality and market positioning.'
Competitive Moat Through Vertical Integration
Unlike competitors focused solely on manufacturing or retail, Aquaox's vertically integrated approach—from proprietary nanobubble technology through FDA-compliant manufacturing to direct consumer sales—creates multiple revenue streams and competitive advantages:
Industry Leadership in Emerging Category
As traditional antiseptic and personal care companies face increasing regulatory scrutiny and consumer backlash against harsh chemicals, Aquaox has positioned itself as the category leader in next-generation HOCl solutions. The company's comprehensive platform addresses every aspect of the value chain, from technology development through regulatory compliance to market distribution.
'We're not just building a product company—we're building the infrastructure for an entire category,' said Van Schaik. 'While others focus on individual products, we're creating the platform that enables the whole HOCl market to scale.'
About the Growing HOCl Market
Hypochlorous acid represents one of the fastest-growing segments in both personal care and healthcare, driven by increasing consumer awareness of its safety profile and efficacy. Unlike traditional antiseptics, HOCl is naturally produced by white blood cells and breaks down into salt and water, making it ideal for sensitive skin applications and frequent use scenarios.
Cognitive Market Research estimates the HOCl the 2025 Market size to be US $6.852 billion with a projected CAGR of ~5.9% from 2025 to 2033.
Investment Positioning
Full Alliance Group's investment in Aquaox Pure Solutions represents a strategic play on multiple converging trends: clean beauty adoption, regulatory tightening in personal care, and the shift toward science-backed wellness solutions. The company's early-mover advantage in FDA-compliant HOCl manufacturing positions it to capture significant market share as the category matures.
About Aquaox Pure Solutions, LLC Aquaox Pure Solutions is the leading advanced hypochlorous acid manufacturing platform, specializing in ultra-pure, shelf-stable, and clinically validated HOCl solutions. Through proprietary nanobubble technology and GMP-compliant infrastructure, Aquaox serves the growing demand for clean, effective alternatives across medical, consumer, and industrial markets.
About Full Alliance Group, Inc. (OTC: FAGI) Full Alliance Group is a diversified holding company focused on scaling high-growth businesses in health, science, and sustainability. Through strategic subsidiaries including Aquaox Pure Solutions, Full Alliance builds market-leading platforms that capitalize on emerging consumer trends while delivering sustainable shareholder value.
Investor & Media Contact:
Investor Relations [email protected]
www.fullalliance-group.com
Consumer Product: www.tryjusspray.com
B2B Manufacturing: www.PureAquaox.com
This press release contains forward-looking statements. Market data sourced from industry research reports and company analysis.
Media Contact:
Full Alliance Group Inc. Investor Relations
Gabe Rodriguez, Erelations Group
[email protected]
(623) 261-9046
Pure Aquaox Solutions, LLC
Brett Phillips
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, including but not limited to statements regarding future financial performance, business strategy, and plans and objectives for future operations. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied by such forward-looking statements.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/dfb3ce92-6a89-42af-9134-f41eb35a73be
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
MSA Safety (MSA) Reports Q2: Everything You Need To Know Ahead Of Earnings
Safety equipment manufacturer MSA Safety (NYSE:MSA) will be reporting results this Monday afternoon. Here's what to look for. MSA Safety beat analysts' revenue expectations by 5% last quarter, reporting revenues of $421.3 million, up 1.9% year on year. It was an exceptional quarter for the company, with an impressive beat of analysts' EPS estimates. Is MSA Safety a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting MSA Safety's revenue to decline 3.2% year on year to $447.8 million, a reversal from the 3.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.76 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. MSA Safety has missed Wall Street's revenue estimates three times over the last two years. Looking at MSA Safety's peers in the business services & supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. HNI delivered year-on-year revenue growth of 7%, beating analysts' expectations by 3.2%, and MillerKnoll reported revenues up 8.2%, topping estimates by 5.3%. HNI's stock price was unchanged after the resultswhile MillerKnoll was up 12.2%. Read our full analysis of HNI's results here and MillerKnoll's results here. Questions about potential tariffs and corporate tax changes have caused much volatility in 2025. While some of the business services & supplies stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.4% on average over the last month. MSA Safety is up 2.2% during the same time and is heading into earnings with an average analyst price target of $182.20 (compared to the current share price of $175.23). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Yahoo
4 minutes ago
- Yahoo
Tyson Foods (TSN) Reports Q2: Everything You Need To Know Ahead Of Earnings
Meat company Tyson Foods (NYSE:TSN) will be reporting earnings this Monday morning. Here's what to look for. Tyson Foods missed analysts' revenue expectations by 0.7% last quarter, reporting revenues of $13.07 billion, flat year on year. It was a strong quarter for the company, with an impressive beat of analysts' EBITDA estimates and a decent beat of analysts' EPS estimates. Is Tyson Foods a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Tyson Foods's revenue to be flat year on year at $13.5 billion, slowing from the 2% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.78 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Tyson Foods has missed Wall Street's revenue estimates five times over the last two years. Looking at Tyson Foods's peers in the perishable food segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Fresh Del Monte Produce delivered year-on-year revenue growth of 3.8%, beating analysts' expectations by 2.2%, and Cal-Maine reported revenues up 72.2%, topping estimates by 21.3%. Fresh Del Monte Produce traded up 4.2% following the results while Cal-Maine was also up 13.6%. Read our full analysis of Fresh Del Monte Produce's results here and Cal-Maine's results here. Debates around the economy's health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the perishable food stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.4% on average over the last month. Tyson Foods is down 5.8% during the same time and is heading into earnings with an average analyst price target of $63.17 (compared to the current share price of $52.53). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Yahoo
4 minutes ago
- Yahoo
What To Expect From Lindblad Expeditions's (LIND) Q2 Earnings
Cruise and exploration company Lindblad Expeditions (NASDAQ:LIND) will be reporting results this Monday before market open. Here's what you need to know. Lindblad Expeditions beat analysts' revenue expectations by 18.8% last quarter, reporting revenues of $179.7 million, up 17% year on year. It was an exceptional quarter for the company, with an impressive beat of analysts' EPS estimates and a solid beat of analysts' EBITDA estimates. Is Lindblad Expeditions a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Lindblad Expeditions's revenue to grow 16.5% year on year to $159 million, improving from the 9.4% increase it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.29 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Lindblad Expeditions has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 5.8% on average. Looking at Lindblad Expeditions's peers in the travel and vacation providers segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Carnival delivered year-on-year revenue growth of 9.5%, beating analysts' expectations by 1.7%, and Delta reported flat revenue, topping estimates by 1.5%. Carnival traded up 5.9% following the results while Delta was also up 11.9%. Read our full analysis of Carnival's results here and Delta's results here. Investors in the travel and vacation providers segment have had steady hands going into earnings, with share prices flat over the last month. Lindblad Expeditions is down 7.4% during the same time and is heading into earnings with an average analyst price target of $15 (compared to the current share price of $11.73). Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
